When should patients and family members undergo genetic assessment for a heart condition? Find out in an international consensus document published in EP Europace, a journal of the European Society of Cardiology (ESC) and ...
Apr 4, 2022
0
0
Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.
Mar 30, 2022
0
2
The sad passing of Kimberley Kitching and Shane Warne (both 52) from suspected cardiac conditions has put a spotlight on the causes of heart disease.
Mar 21, 2022
0
8
Led by Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions, including a team from the University of Glasgow, worked together as part of the DISCHARGE trial. The aim of the trial was ...
Mar 15, 2022
0
179
A new study by researchers at The Ohio State University College of Medicine gives insight into what happens to the cardiovascular system of adolescents when they vape.
Feb 21, 2022
0
139
In collaboration with the International Council of Cardiovascular Prevention and Rehabilitation, researchers from York and Qatar Universities have launched the first-of-its-kind International Cardiac Rehabilitation Registry ...
Jan 11, 2022
0
15
A novel artificial intelligence score provides a more accurate forecast of the likelihood of patients with suspected or known coronary artery disease dying within 10 years than established scores used by health professionals ...
Dec 11, 2021
0
43
Spiny mice, known for their unique ability to regrow lost skin, may also be able to preserve injured cardiac tissue according to a new study conducted by a research team from the University of Kentucky College of Medicine ...
Dec 9, 2021
0
50
The risk of developing cardiovascular disease is strongly associated with the "bad" LDL cholesterol. A large study by scientists at Karolinska Institutet now shows that two proteins that transport cholesterol particles in ...
Dec 1, 2021
0
123
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical ...
Nov 17, 2021
0
75
